Cargando…
Eotaxin-3 as a Plasma Biomarker for Mucosal Eosinophil Infiltration in Chronic Rhinosinusitis
Objective: Chronic rhinosinusitis with nasal polyps exhibits marked eosinophilic infiltration and its mucosal eosinophilia is associated with more severe symptoms. The Japanese epidemiological survey of refractory eosinophilic chronic rhinosinusitis found that patients with nasal polyps required mul...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369170/ https://www.ncbi.nlm.nih.gov/pubmed/30778348 http://dx.doi.org/10.3389/fimmu.2019.00074 |
_version_ | 1783394127502639104 |
---|---|
author | Yamada, Takechiyo Miyabe, Yui Ueki, Shigeharu Fujieda, Shigeharu Tokunaga, Takahiro Sakashita, Masafumi Kato, Yukinori Ninomiya, Takahiro Kawasaki, Yohei Suzuki, Shinsuke Saito, Hidekazu |
author_facet | Yamada, Takechiyo Miyabe, Yui Ueki, Shigeharu Fujieda, Shigeharu Tokunaga, Takahiro Sakashita, Masafumi Kato, Yukinori Ninomiya, Takahiro Kawasaki, Yohei Suzuki, Shinsuke Saito, Hidekazu |
author_sort | Yamada, Takechiyo |
collection | PubMed |
description | Objective: Chronic rhinosinusitis with nasal polyps exhibits marked eosinophilic infiltration and its mucosal eosinophilia is associated with more severe symptoms. The Japanese epidemiological survey of refractory eosinophilic chronic rhinosinusitis found that patients with nasal polyps required multiple surgeries when there were higher infiltrating eosinophils in the mucosa. In order to identify plasma biomarkers for local eosinophil infiltration in rhinosinusitis for surgery, we examined the levels of molecules in the plasma of patients and compared the number of infiltrating eosinophils in the nasal mucosa. Materials and Methods: Mucosal tissues from 97 patients with chronic rhinosinusitis (CRS) were obtained from the nasal polyps during surgery. Tissues were immediately fixed and sections were stained with hematoxylin-eosin. The number of eosinophils in the mucosa was counted at HPF (x 400). Blood samples were obtained and the plasma was stored at −80°C. We measured the plasma cytokine and chemokine levels using multiple assay systems according to the manufacturers' protocols. The tissues were divided into high- and low-eosinophil mucosal infiltration group for recurrence after endoscopic sinus surgery (ESS). We also observed chemokine secretion from nasal fibroblasts. Results: The plasma level of eotaxin-3/ CC chemokine ligand 26 (CCL26) was significantly higher in the high-eosinophil mucosal infiltration group (p < 0.005). The number of infiltrating eosinophils in the mucosa was significantly higher in the group with the higher eotaxin-3 level (p < 0.001), but there was no significant difference in the blood eosinophil numbers among two groups. A significant positive correlation was found between the mucosal eosinophil count and the plasma levels of eotaxin-3 (p < 0.005). The levels of interleukin 33 (IL-33) (p < 0.001) and thymic stromal-derived lymphopoietin (TSLP) (p < 0.005) were significantly higher in the high-level eotaxin-3 group. IL-13 strongly induced the secretion of eotaxin-3 from human nasal fibroblasts (p < 0.05). Conclusion: This is the first report suggesting eotaxin-3 as a plasma biomarker for mucosal eosinophil infiltration. Furthermore, the level of eotaxin-3 was found to be closely related to IL-33 and TSLP levels which indicate respiratory diseases. |
format | Online Article Text |
id | pubmed-6369170 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-63691702019-02-18 Eotaxin-3 as a Plasma Biomarker for Mucosal Eosinophil Infiltration in Chronic Rhinosinusitis Yamada, Takechiyo Miyabe, Yui Ueki, Shigeharu Fujieda, Shigeharu Tokunaga, Takahiro Sakashita, Masafumi Kato, Yukinori Ninomiya, Takahiro Kawasaki, Yohei Suzuki, Shinsuke Saito, Hidekazu Front Immunol Immunology Objective: Chronic rhinosinusitis with nasal polyps exhibits marked eosinophilic infiltration and its mucosal eosinophilia is associated with more severe symptoms. The Japanese epidemiological survey of refractory eosinophilic chronic rhinosinusitis found that patients with nasal polyps required multiple surgeries when there were higher infiltrating eosinophils in the mucosa. In order to identify plasma biomarkers for local eosinophil infiltration in rhinosinusitis for surgery, we examined the levels of molecules in the plasma of patients and compared the number of infiltrating eosinophils in the nasal mucosa. Materials and Methods: Mucosal tissues from 97 patients with chronic rhinosinusitis (CRS) were obtained from the nasal polyps during surgery. Tissues were immediately fixed and sections were stained with hematoxylin-eosin. The number of eosinophils in the mucosa was counted at HPF (x 400). Blood samples were obtained and the plasma was stored at −80°C. We measured the plasma cytokine and chemokine levels using multiple assay systems according to the manufacturers' protocols. The tissues were divided into high- and low-eosinophil mucosal infiltration group for recurrence after endoscopic sinus surgery (ESS). We also observed chemokine secretion from nasal fibroblasts. Results: The plasma level of eotaxin-3/ CC chemokine ligand 26 (CCL26) was significantly higher in the high-eosinophil mucosal infiltration group (p < 0.005). The number of infiltrating eosinophils in the mucosa was significantly higher in the group with the higher eotaxin-3 level (p < 0.001), but there was no significant difference in the blood eosinophil numbers among two groups. A significant positive correlation was found between the mucosal eosinophil count and the plasma levels of eotaxin-3 (p < 0.005). The levels of interleukin 33 (IL-33) (p < 0.001) and thymic stromal-derived lymphopoietin (TSLP) (p < 0.005) were significantly higher in the high-level eotaxin-3 group. IL-13 strongly induced the secretion of eotaxin-3 from human nasal fibroblasts (p < 0.05). Conclusion: This is the first report suggesting eotaxin-3 as a plasma biomarker for mucosal eosinophil infiltration. Furthermore, the level of eotaxin-3 was found to be closely related to IL-33 and TSLP levels which indicate respiratory diseases. Frontiers Media S.A. 2019-02-04 /pmc/articles/PMC6369170/ /pubmed/30778348 http://dx.doi.org/10.3389/fimmu.2019.00074 Text en Copyright © 2019 Yamada, Miyabe, Ueki, Fujieda, Tokunaga, Sakashita, Kato, Ninomiya, Kawasaki, Suzuki and Saito. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Yamada, Takechiyo Miyabe, Yui Ueki, Shigeharu Fujieda, Shigeharu Tokunaga, Takahiro Sakashita, Masafumi Kato, Yukinori Ninomiya, Takahiro Kawasaki, Yohei Suzuki, Shinsuke Saito, Hidekazu Eotaxin-3 as a Plasma Biomarker for Mucosal Eosinophil Infiltration in Chronic Rhinosinusitis |
title | Eotaxin-3 as a Plasma Biomarker for Mucosal Eosinophil Infiltration in Chronic Rhinosinusitis |
title_full | Eotaxin-3 as a Plasma Biomarker for Mucosal Eosinophil Infiltration in Chronic Rhinosinusitis |
title_fullStr | Eotaxin-3 as a Plasma Biomarker for Mucosal Eosinophil Infiltration in Chronic Rhinosinusitis |
title_full_unstemmed | Eotaxin-3 as a Plasma Biomarker for Mucosal Eosinophil Infiltration in Chronic Rhinosinusitis |
title_short | Eotaxin-3 as a Plasma Biomarker for Mucosal Eosinophil Infiltration in Chronic Rhinosinusitis |
title_sort | eotaxin-3 as a plasma biomarker for mucosal eosinophil infiltration in chronic rhinosinusitis |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6369170/ https://www.ncbi.nlm.nih.gov/pubmed/30778348 http://dx.doi.org/10.3389/fimmu.2019.00074 |
work_keys_str_mv | AT yamadatakechiyo eotaxin3asaplasmabiomarkerformucosaleosinophilinfiltrationinchronicrhinosinusitis AT miyabeyui eotaxin3asaplasmabiomarkerformucosaleosinophilinfiltrationinchronicrhinosinusitis AT uekishigeharu eotaxin3asaplasmabiomarkerformucosaleosinophilinfiltrationinchronicrhinosinusitis AT fujiedashigeharu eotaxin3asaplasmabiomarkerformucosaleosinophilinfiltrationinchronicrhinosinusitis AT tokunagatakahiro eotaxin3asaplasmabiomarkerformucosaleosinophilinfiltrationinchronicrhinosinusitis AT sakashitamasafumi eotaxin3asaplasmabiomarkerformucosaleosinophilinfiltrationinchronicrhinosinusitis AT katoyukinori eotaxin3asaplasmabiomarkerformucosaleosinophilinfiltrationinchronicrhinosinusitis AT ninomiyatakahiro eotaxin3asaplasmabiomarkerformucosaleosinophilinfiltrationinchronicrhinosinusitis AT kawasakiyohei eotaxin3asaplasmabiomarkerformucosaleosinophilinfiltrationinchronicrhinosinusitis AT suzukishinsuke eotaxin3asaplasmabiomarkerformucosaleosinophilinfiltrationinchronicrhinosinusitis AT saitohidekazu eotaxin3asaplasmabiomarkerformucosaleosinophilinfiltrationinchronicrhinosinusitis |